NCT00220857View on ClinicalTrials.gov

Rabeprazole Protection of Aspirin Induced Gastric Damage.

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Normal Subjects
Interventions
DRUG

Rabeprazole

Trial Locations (1)

19140

Temple University School of Medicine, Philadelphia

All Listed Sponsors
lead

Temple University

OTHER

NCT00220857 - Rabeprazole Protection of Aspirin Induced Gastric Damage. | Biotech Hunter | Biotech Hunter